Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Exelixis
ClinicalTrials.gov Identifier:
NCT00940225
First received: July 12, 2009
Last updated: February 18, 2015
Last verified: February 2015